JOHNSON & JOHNSON Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Johnson & Johnson quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
Johnson & Johnson Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $1.06B, a 14.2% increase year-over-year.
Johnson & Johnson Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $3.12B, a 126% increase year-over-year.
Johnson & Johnson annual Income Tax Expense (Benefit) for 2023 was $1.74B, a 41.9% decline from 2022.
Johnson & Johnson annual Income Tax Expense (Benefit) for 2022 was $2.99B, a 117% increase from 2021.
Johnson & Johnson annual Income Tax Expense (Benefit) for 2021 was $1.38B, a 22.8% decline from 2020.

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$3.12B	$1.06B	+$132M	+14.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-25
Q1 2024	$2.99B	$459M	+$1.26B		Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-01
Q4 2023	$1.74B	$694M	+$306M	+78.9%	Oct 2, 2023	Dec 31, 2023	10-K	2024-02-16
Q3 2023	$1.43B	$908M	+$46M	+5.34%	Jul 3, 2023	Oct 1, 2023	10-Q	2023-10-27
Q2 2023	$1.38B	$930M	-$96M	-9.36%	Apr 3, 2023	Jul 2, 2023	10-Q	2024-07-25
Q1 2023	$1.48B	-$796M	-$1.51B	-212%	Jan 2, 2023	Apr 2, 2023	10-Q	2024-05-01
Q4 2022	$2.99B	$388M	+$809M		Oct 3, 2022	Jan 1, 2023	10-K	2024-02-16
Q3 2022	$2.18B	$862M	+$680M	+374%	Jul 4, 2022	Oct 2, 2022	10-Q	2023-10-27
Q2 2022	$1.5B	$1.03B	+$642M	+167%	Apr 4, 2022	Jul 3, 2022	10-Q	2023-07-31
Q1 2022	$858M	$713M	-$519M	-42.1%	Jan 3, 2022	Apr 3, 2022	10-Q	2023-04-28
Q4 2021	$1.38B	-$421M	-$330M	-363%	Oct 4, 2021	Jan 2, 2022	10-K	2024-02-16
Q3 2021	$1.71B	$182M	-$665M	-78.5%	Jul 5, 2021	Oct 3, 2021	10-Q	2022-10-27
Q2 2021	$2.37B	$384M	+$70M	+22.3%	Apr 5, 2021	Jul 4, 2021	10-Q	2022-07-29
Q1 2021	$2.3B	$1.23B	+$519M	+72.8%	Jan 4, 2021	Apr 4, 2021	10-Q	2022-04-29
Q4 2020	$1.78B	-$91M	-$299M	-144%	Sep 28, 2020	Jan 3, 2021	10-K	2023-02-16
Q3 2020	$2.08B	$847M	+$953M		Jun 29, 2020	Sep 27, 2020	10-Q	2021-10-29
Q2 2020	$1.13B	$314M	-$1.12B	-78.1%	Mar 30, 2020	Jun 28, 2020	10-Q	2021-07-29
Q1 2020	$2.25B	$713M	+$40M	+5.94%	Dec 30, 2019	Mar 29, 2020	10-Q	2021-04-30
Q4 2019	$2.21B	$208M	+$128M	+160%	Sep 30, 2019	Dec 29, 2019	10-K	2022-02-17
Q3 2019	$2.08B	-$106M	-$595M	-122%	Jul 1, 2019	Sep 29, 2019	10-Q	2020-10-23
Q2 2019	$2.68B	$1.43B	+$415M	+40.7%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-24
Q1 2019	$2.26B	$673M	-$441M	-39.6%	Dec 31, 2018	Mar 31, 2019	10-Q	2020-04-29
Q4 2018	$2.7B	$80M	-$13.2B	-99.4%	Oct 1, 2018	Dec 30, 2018	10-K	2021-02-22
Q3 2018	$15.9B	$489M	-$537M	-52.3%	Jul 2, 2018	Sep 30, 2018	10-Q	2019-10-28
Q2 2018	$16.4B	$1.02B	+$98M	+10.6%	Apr 2, 2018	Jul 1, 2018	10-Q	2019-07-29
Q1 2018	$16.3B	$1.11B	-$39M	-3.38%	Jan 1, 2018	Apr 1, 2018	10-Q	2019-05-01
Q4 2017	$16.4B	$13.3B	+$12.8B	+2503%	Oct 2, 2017	Dec 31, 2017	10-K	2020-02-18
Q3 2017	$3.61B	$1.03B	+$17M	+1.69%	Jul 3, 2017	Oct 1, 2017	10-Q	2018-10-31
Q2 2017	$3.59B	$921M	+$14M	+1.54%	Apr 3, 2017	Jul 2, 2017	10-Q	2018-08-02
Q1 2017	$3.58B	$1.15B	+$316M	+37.8%	Jan 2, 2017	Apr 2, 2017	10-Q	2018-05-01
Q4 2016	$3.26B	$510M	-$33M	-6.08%	Oct 3, 2016	Jan 1, 2017	10-K	2019-02-20
Q3 2016	$3.3B	$1.01B	+$245M	+32.1%	Jul 4, 2016	Oct 2, 2016	10-Q	2017-11-02
Q2 2016	$3.05B	$907M	-$318M	-26%	Apr 4, 2016	Jul 3, 2016	10-Q	2017-08-03
Q1 2016	$3.37B	$837M	-$418M	-33.3%	Jan 4, 2016	Apr 3, 2016	10-Q	2017-05-08
Q4 2015	$3.79B	$543M	+$361M	+198%	Sep 28, 2015	Jan 3, 2016	10-K	2018-02-21
Q3 2015	$3.43B	$764M	-$1.3B	-62.9%	Jun 29, 2015	Sep 27, 2015	10-Q	2016-11-04
Q2 2015	$4.72B	$1.23B	-$75M	-5.77%	Mar 30, 2015	Jun 28, 2015	10-Q	2016-08-04
Q1 2015	$4.8B	$1.26B	+$558M	+80.1%	Dec 29, 2014	Mar 29, 2015	10-Q	2016-05-10
Q4 2014	$4.24B	$182M	+$951M		Sep 29, 2014	Dec 28, 2014	10-K	2017-02-27
Q3 2014	$3.29B	$2.06B	+$1.38B	+201%	Jun 30, 2014	Sep 28, 2014	10-Q	2015-10-30
Q2 2014	$1.91B	$1.3B	+$340M	+35.4%	Mar 31, 2014	Jun 29, 2014	10-Q	2015-07-31
Q1 2014	$1.57B	$697M	-$67M	-8.77%	Dec 30, 2013	Mar 30, 2014	10-Q	2015-05-01
Q4 2013	$1.64B	-$769M	-$1.3B	-244%	Sep 30, 2013	Dec 29, 2013	10-K	2016-02-24
Q3 2013	$2.94B	$685M	-$281M	-29.1%	Jul 1, 2013	Sep 29, 2013	10-Q	2014-10-30
Q2 2013	$3.22B	$960M	+$333M	+53.1%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-01
Q1 2013	$2.89B	$764M	-$371M	-32.7%	Dec 31, 2012	Mar 31, 2013	10-Q	2014-05-02
Q4 2012	$3.26B	$533M	+$433M	+433%	Oct 1, 2012	Dec 30, 2012	10-K	2015-02-24
Q3 2012	$2.83B	$966M	+$57M	+6.27%	Jul 2, 2012	Sep 30, 2012	10-Q	2013-11-04
Q2 2012	$2.77B	$627M	-$19M	-2.94%	Apr 2, 2012	Jul 1, 2012	10-Q	2013-08-01
Q1 2012	$2.79B	$1.14B	+$101M	+9.77%	Jan 2, 2012	Apr 1, 2012	10-Q	2013-05-03
Q4 2011	$2.69B	$100M	-$186M	-65%	Oct 3, 2011	Jan 1, 2012	10-K	2014-02-21
Q3 2011	$2.88B	$909M	+$107M	+13.3%	Jul 4, 2011	Oct 2, 2011	10-Q	2012-11-09
Q2 2011	$2.77B	$646M	-$125M	-16.2%	Apr 4, 2011	Jul 3, 2011	10-Q	2012-08-02
Q1 2011	$2.89B	$1.03B	-$720M	-41%	Jan 3, 2011	Apr 3, 2011	10-Q	2012-05-07
Q4 2010	$3.61B	$286M			Oct 4, 2010	Jan 2, 2011	10-K	2013-02-22
Q3 2010		$802M			Jul 5, 2010	Oct 3, 2010	10-Q	2011-11-08
Q2 2010		$771M			Apr 5, 2010	Jul 4, 2010	10-Q	2011-08-09
Q1 2010		$1.75B			Jan 4, 2010	Apr 4, 2010	10-Q	2011-05-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.